Administering medications to veterinary patients can be a challenging task for owners. Palatability issues with bitter drugs is very common and masking the taste of these drugs can be difficult. The logistics of simply giving an oral medication to pets often exacerbate existing challenges. However, delivering medications through the skin using permeation-enhancing vehicles may provide welcomed options for veterinarians and their patients, and serves as a prime example of how compounding shines by offering alternative delivery systems.

As a popular speaker, Tim makes information entertaining, memorable and easy to understand. Gain insight now on effective presentation techniques to market your compounding pharmacy to prescribers and patients in your community.

Our Profiles in Personalized Medicine highlights Amanda Beliveau, CPhT, Lab Manager at Montana Apothecary & Compounding, owned by Shelbi Witt, PharmD, and located in Great Falls, Montana. We asked Amanda what “Compounding: It’s Personal” means to her, why she pursued compounding as a career and much more.

As compounders, we work with a variety of active pharmaceutical ingredients (APIs), some of which are more challenging to compound than others. Compounding with methylene blue as an API has risen due to emerging research for a variety of clinical applications. However, methylene blue can be intimidating to compound due to its intense blue color, which may stain costly lab equipment, countertops and other materials. Discover some useful techniques that can ease the sometimes stressful process of working with this vibrant API.

Vulvodynia, a condition shrouded in mystery, affects 7% of American women and many times is misdiagnosed as vaginitis.1 The chronic vulvar pain disorder — often described as itching, burning or stabbing sensations — presents symptoms ranging from persistent discomfort to pain during intimacy.2 To better assist patients, we will explore the signs and symptoms of vulvodynia, illuminate the connection with pelvic floor dysfunction and discuss various ways to help patients: topical medications, pelvic floor physical therapy and the intriguing world of acupuncture.

Our Profiles in Personalized Medicine highlights PCCA’s 2023 award winners: Igor Shaskin, BScPharm; Kevin Borg, PharmD; Ashley Berthelot; and Dayna Timmer, PharmD. We asked each winner to discuss what “Compounding: It’s Personal” means in their pharmacy, as well as share their patient and personal success stories and favorite PCCA bases.

Although January is National Thyroid Month, our Clinical Services team gets a lot of queries throughout the year on managing thyroid patients, including those with autoimmune conditions such as Graves’ disease (GD) and Hashimoto's thyroiditis (HT). While thyroid clinical management may seem complicated, understanding some basics of thyroid physiology and the pathophysiology of these autoimmune diseases may help make a difference in patients’ lives.

The human body is a complex network of interconnected systems, and recent research has shed light on the intricate relationship between visceral adipose tissue (VAT), estradiol levels and cognitive health.

On November 1, 2023, revisions to USP Chapter 795 and Chapter 797 became official and made USP 800 compendially applicable and potentially enforceable. However, other regulatory agencies — including state boards of pharmacy and the FDA — may impact whether USP 800 is enforceable in your pharmacy.

At the beginning of a new year, many people begin a detoxification and weight loss journey as part of their annual resolutions or to recover from over-indulging during the holidays. But in an environment where most are exposed to a variety of foreign contaminants daily, practices that help minimize or remove chemicals unknowingly stored in the body have become an important habit throughout the year.